Senseonics to Present at the Stifel 2022 Healthcare Conference
11/09/2022
|
|
Senseonics Holdings, Inc. Reports Third Quarter 2022 Financial Results
11/08/2022
|
|
Senseonics and Ascensia Announce a Collaboration with the Nurse Practitioner Group Designed to Expand Patient Access by Providing In-Office and At-Home Insertion Options for Eversense® E3 Continuous Glucose Monitoring System (CGM)
11/03/2022
|
|
Senseonics Holdings, Inc. Schedules Third Quarter 2022 Earnings Release and Conference Call for November 8, 2022, at 4:30 p.m. Eastern Time
10/25/2022
|
|
Senseonics Announces Equity Grants To Employees Under Inducement Plan
10/06/2022
|
|
Senseonics to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference
09/07/2022
|
|
Senseonics Announces CFO Transition
09/01/2022
|
|
Senseonics to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase
08/17/2022
|
|
Senseonics Holdings, Inc. Reports Second Quarter 2022 Financial Results
08/09/2022
|
|
Senseonics Announces a Positive Coverage Decision for Eversense® E3 CGM from Anthem
08/03/2022
|
|